J. de Mouzon

ORCID: 0000-0002-9465-3488 · 5 papers in corpus
observational 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.11.017

RESEARCH QUESTION: Does endometriosis increase obstetric and neonatal complications, and does assisted reproductive technology (ART) cause additional risk of maternal or fetal morbidity? DESIGN: A nationwide cohort study (2013-2018) compar…

review 2017
Human reproduction open ·doi:10.1093/hropen/hox003

STUDY QUESTION: What is known in Europe about the practice of oocyte cryopreservation (OoC), in terms of current statutory background, funding conditions, indications (medical and 'non-medical') and specific number of cycles? SUMMARY ANSWE…

observational 2012
Human Reproduction ·doi:10.1093/humrep/des274

STUDY QUESTION: Are anti-Müllerian hormone (AMH) levels lower in women with endometriosis, notably those with endometriomas (OMAs) and deep infiltrating lesions, compared with controls without endometriosis? SUMMARY ANSWER: Endometriosis a…

rct 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.05.056

In women with endometriosis, including those with endometriomas, 6 to 8 weeks of continuous use of oral contraception (OC) before assisted reproduction treatment (ART) maintains ART outcomes comparable with the outcomes of age-matched contr…

2007
·doi:10.1093/humrep/dem1053

Objectives: To evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on adenomyotic lesions diagnosed and monitored by magnetic resonance imaging (MRI). Design: A prospective descriptive study. Setting: Tertiary …